[journal]
권미란
/ 2009
/ 건강권을 넘어선 재산권, 이에 맞서는 의약품 접근권 투쟁
/ 사회운동
86
[confproc]
권미란
/ 2013
/ 의약품 특허 vs. 의약품 접근권 동향
/ ‘우리이웃의 괴물, 특허와 저작권’ 발표문
[report]
김대중
/ 2012
/ 보건의료분야 시장개방 이슈와 대응방안 연구 - 한미FTA를 중심으로
/ 한국보건사회연구원
[journal]
김재원
/ 1999
/ 지적재산권의 법철학적 재검토
/ 경남법학
15
: 261~278
[thesis]
박혜경
/ 1997
/ 한국 제약산업의 연구개발 및 기술협력 추이에 관한 연구 : 물질특허 도입전후 비교를 중심으로
/ 석사
/ 서울大學校 保健大學院
[book]
변진옥
/ 2012
/ 한미 FTA가 국민건강보험에 미치는 영향과 대응
/ 국민건강보험 건강보험정책연구원
[thesis]
서보경
/ 2008
/ 태국 에이즈 감염인의 의약품 접근권 운동
/ 석사
/ 서울대학교 대학원
[book]
수전 K. Sell
/ 2009
/ 초국적 기업에 의한 법의 지배
/ 후마니타스
[report]
이근찬
/ 2009
/ 2009년 의약품 산업 분석 보고서
/ 한국보건산업진흥원
[thesis]
이모세
/ 1995
/ 물질특허도입 전후 의약품시장의 구조변화에 관한 연구
/ 석사
/ 서울大學校 保健大學院
[report]
이성봉
/ 2006
/ 한미 FTA 투자분야 주요 쟁점이슈와 평가
/ 대외경제정책연구원
[thesis]
이효원
/ 2008
/ 국제 지적재산권 레짐의 형성과 운영 : TRIPs 협정의 한계
/ 석사
/ 연세대학교 대학원
[book]
장하준
/ 2004
/ 사다리 걷어차기
/ 도서출판 부키
[other]
정보공유연대
/ 2013
/ 인도대법원 판결: 노바티스 패소, 특허독점에 맞선 전 세계 환자들의 승리
/ 주간 정보공유동향
[report]
조승수 의원실
/ 2009
/ 특허발명의 정부사용 제도 개선방안
[report]
한미 FTA 저지 범국민 운동본부
/ 2011
/ 2011년 한미 FTA 국민보고서
[thesis]
Abughanm, S.
/ 2012
/ The protection of pharmaceutical patents and data under TRIPS and US-Jordan FTA: exploring the limits of obligations and flexibilities: a study of the impacts on the pharmaceutical sector in Jordan
/ 박사
/ University of Toronto
[book]
Amin, T.
/ 2007
/ Voluntary licensing practices in the pharmaceutical sector: an acceptable solution to improving access to affordable medicines
/ Oxfam GB
[journal]
Babovic, S.
/ 2011
/ Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals
/ Journal of pharmaceutical sciences
100(3)
: 816~821
[report]
Central Bank of Jordan
/ 2006
/ Annual report 2006. Amman: Department of Research and Studies
/ Central Bank of Jordan
[journal]
Chadha, A.
/ 2009
/ TRIPs and patenting activity: Evidence from the Indian pharmaceutical industry
/ Economic Modelling
26(2)
: 499~505
[report]
Chaudhuri, S.
/ 2011
/ Multinationals and monopolies: pharmaceutical industry in india after TRIPS
/ Indian Institute of Management Calcuta
[report]
Chaudhuri, S.
/ 2010
/ Five years into the product patent regime: India’s response
/ United Nations Development Programme
[book]
Correa, C. M.
/ 2000
/ Intellectual property rights, the WTO, and developing countries: the TRIPS agreement and policy options
/ Zed books
[journal]
Correa, C. M.
/ 2006
/ Implications of bilateral free trade agreements on access to medicines
/ Bulletin of the World Health Organization
84(5)
: 399~404
[journal]
Danzon, P. M.
/ 2003
/ Prices and availability of pharmaceuticals : evidence from nine countries
/ Health Affairs
3
: 521~
[book]
Docteur, E.
/ 2008
/ Pharmaceutical pricing policies in a global marke
/ OECD
[report]
Duggan, M.
/ 2012
/ Pharmaceutical patents and prices: a preliminary empirical assessment using data from India
/ World Bank
[journal]
El-Said, H.
/ 2007
/ TRIPS-Plus implications for access to medicines in developing countries : lessons from Jordan–United States Free Trade Agreement
/ The Journal of World Intellectual Property
10(6)
: 438~475
[journal]
Faunce, T.
/ 2010
/ Impact of the Australia-US Free Trade Agreement on Australian medicines regulation and prices
/ Journal of Generic Medicines
7(1)
: 18~29
[journal]
Faunce, T. A.
/ 2007
/ Reference pricing for pharmaceuticals: is the Australia-United States Free Trade Agreement affecting Australia’s Pharmaceutical Benefits Scheme?
/ Medical Journal of Australia
187(4)
: 240~
[journal]
Flynn, S. M.
/ 2010
/ Special 301 of the Trade Act of 1974 and global access to medicines
/ Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
7(4)
: 309~333
[book]
Gonzalez, J. S.
/ 2002
/ Drugs and pharmaceuticals
/ International Trade Administration
[journal]
Grabowski, H.
/ 2002
/ Patents, innovation and access to new pharmaceuticals
/ Journal of International Economic Law
5(4)
: 849~
[other]
Jayakumar, P. B.
/ 2008
/ Small-scale pharmaceutical companies struggling for survival Paper presented at the Business Standard
/ Mumbai
[report]
Jordan Food & Drugs Administration
/ 1999
/ Annual Statistical Report
[journal]
Kumar, A.
/ 2011
/ Financing health care for all: challenges and opportunities
/ The Lancet
377(9766)
: 668~679
[journal]
Lofgren, H.
/ 2009
/ Generic medicines in Australia: business dynamics and recent policy reform
/ Southern Med Review
2(2)
: 24~28
[journal]
Malpani, R.
/ 2009
/ All costs, no benefits: how the US-Jordan Free Trade Agreement affects access to medicines
/ Journal of Generic Medicines : The Business Journal for the Generic Medicines Sector
6(3)
: 206~217
[other]
Market Africa Mid-East
/ 2003
/ Jordan's Pharmaceutical Industry Takes Off
[book]
May, C.
/ 2000
/ A global political economy of intellectual property rights: The new enclosures?
/ Routledge
[journal]
Mazzoleni, R.
/ 1998
/ Economic theories about the benefits and costs of patents
/ Journal of Economic Issues
32(4)
: 1031~1052
[journal]
Mitchell, A.
/ 2006
/ Chemists limit PBS reform
/ Australian Financial Review
58
[journal]
Nicholson, M.
/ 2008
/ Generic explosion or implosion
/ Australian Journal of Pharmacy
89(1)
: 56~59
[journal]
Pecoul, B.
/ 1999
/ Access to essential drugs in poor countries: a lost battle?
/ JAMA
281(4)
: 361~367
[report]
People's Health Movement, Medact, Global Equity Gauge Alliance, & University of South Africa
/ 2005
/ Global health watch 2005-2006: an alternative world health report
/ Zed Books
[journal]
Rein, J.
/ 2000
/ International governance through trade agreements: patent protection for essential medicines
/ Northwestern Journal of International Law & Business
21
: 379~
[book]
Ryan, M. P.
/ 2004
/ Establishing globally competitive pharmaceutical and bio-medical technology industries in Jordan: assessment of business strategies and the enabling environment
/ International Intellectual Property Institute
[journal]
Rylko Bauer, B.
/ 2002
/ Managed care or managed inequality? a call for critiques of market based medicine
/ Medical Anthropology Quarterly
16(4)
: 476~502
[journal]
Searles, A.
/ 2010
/ A preliminary analysis of the pharmaceutical provisions in the Australia-United States Free Trade Agreement on prescription medicines in Australia| NOVA
/ The University of Newcastle's Digital Repository
[book]
Shadlen, K.
/ 2005
/ Policy space for development in the WTO and beyond: the case of intellectual property rights
/ Tufts University
[journal]
Smith, R. D.
/ 2009
/ Trade, TRIPS, and pharmaceuticals
/ The Lancet
373(9664)
: 684~691
[journal]
Troy, E. S. F.
/ 1997
/ Development of modern frameworks for patent protection: Mexico, a model for reform
/ Texas Intellectual Property Law Journal
6
: 133~
[report]
UNDP
/ 2012
/ The potential impact of free trade agreements on public health
[journal]
Waning, B.
/ 2010
/ A lifeline to treatment : the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries
/ Journal of the International AIDS Society
13(1)
: 35~
[thesis]
Warren, B. C.
/ 2012
/ The impact of international trade agreements on health: patent system harmonization and medicines in Mexico
/ 박사
/ The University of British Columbia
[journal]
Zuniga, M. P.
/ 2002
/ Introducing patent protection in the pharmaceutical Sector: a first evaluation of the Mexican case
/ Revue Région et Développement
(16)
: 191~
[journal]
Zuniga, P. U.
/ 1998
/ AIDS in Mexico
/ Journal of the International Association of Physicians in AIDS Care
4(11)
: 29~